Companies: 10,795·Total market cap: $144.5T

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy

FPHAFOTCHealthcare

$3.30

+$0.00(+0.00%)

Market Cap$209542410

P/E Ratio—

52W High$3.3

52W Low$3.3

Avg Volume0

Open$3.30

Beta0.18

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Faron Pharmaceuticals Oy（FPHAF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · FPHAF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-339.00Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding88.5MShares outstanding history

Next EarningsTBAEarnings history

探索 Faron Pharmaceuticals Oy 数据

分析师预测—

股息不分红

盈利EPS $-0.00+99.91%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$25920.00▲ +99.92% YoY

202220232024

FY 2024EPS$-0.00▲ +99.91% YoY

202220232024

TTM:Revenue: $0.00Net Income: -$31.0MEPS: $-339.00View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Faron Pharmaceuticals Oy

$3.30+0.00%$209.5M #2

$11.80+0.00%$170.4M #3

$8.87+0.00%$103.7M #4

$0.36+0.00%$142.5M #5

Broncus Holding Corporation

$0.31+283.75%$161.7M #6

Eupraxia Pharmaceuticals Inc.

$3.04-6.17%$108.3M

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+0.00%

关于 Faron Pharmaceuticals Oy

CEOMarkku Tapani Jalkanen

IPO DateApr 28, 2020

Employees40

CountryFI

Websitefaron.com

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical firm dedicated to drug discovery and development. The company is advancing a pipeline of proprietary drug candidates that harness immune …

Biotechnology HealthcareOTCFI

关于股票概览与关键数据

Faron Pharmaceuticals Oy（FPHAF）是 Biotechnology 行业的 Healthcare 类公司，于 Apr 28, 2020 在 OTC 上市。截至最近交易日，FPHAF 股价为 $3.30，市值约为 $209.5M。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2024 财年 Faron Pharmaceuticals Oy 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Faron Pharmaceuticals Oy（FPHAF）股价为 $3.30，在 OTC 上市，52周区间为 $3.30 – $3.30。

FPHAF 最新股价FPHAF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议